AU2002259005A1 - Compositions and methods for inducing cancer cell death - Google Patents

Compositions and methods for inducing cancer cell death

Info

Publication number
AU2002259005A1
AU2002259005A1 AU2002259005A AU2002259005A AU2002259005A1 AU 2002259005 A1 AU2002259005 A1 AU 2002259005A1 AU 2002259005 A AU2002259005 A AU 2002259005A AU 2002259005 A AU2002259005 A AU 2002259005A AU 2002259005 A1 AU2002259005 A1 AU 2002259005A1
Authority
AU
Australia
Prior art keywords
compositions
methods
cancer cell
cell death
inducing cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002259005A
Inventor
Steven F. Dowdy
Sergei A. Ezhevsky
Jay S. Wadia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU2002259005A1 publication Critical patent/AU2002259005A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2002259005A 2001-04-24 2002-04-24 Compositions and methods for inducing cancer cell death Abandoned AU2002259005A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28609901P 2001-04-24 2001-04-24
US60/286,099 2001-04-24
PCT/US2002/013092 WO2002085305A2 (en) 2001-04-24 2002-04-24 Compositions and methods for inducing cancer cell death

Publications (1)

Publication Number Publication Date
AU2002259005A1 true AU2002259005A1 (en) 2002-11-05

Family

ID=23097063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002259005A Abandoned AU2002259005A1 (en) 2001-04-24 2002-04-24 Compositions and methods for inducing cancer cell death

Country Status (2)

Country Link
AU (1) AU2002259005A1 (en)
WO (1) WO2002085305A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1377667T3 (en) * 2001-03-30 2009-03-30 Leadd Bv Fusion proteins for specific treatment of cancer and autoimmune diseases
CA2529752A1 (en) * 2003-06-20 2005-09-15 The Regents Of The University Of California Polypeptide transduction and fusogenic peptides
WO2006114478A1 (en) * 2005-04-26 2006-11-02 Karyon-Ctt Ltd Diagnostic and therapeutic agents
CN101081871A (en) * 2006-05-31 2007-12-05 华中科技大学 Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof
CN101747437B (en) * 2008-12-10 2012-09-26 浙江日升昌药业有限公司 Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1188832A1 (en) * 2000-09-08 2002-03-20 Leadd B.V. A delivery method for the tumor specific apoptosis inducing activity of apoptin
ES2200065T3 (en) * 1995-06-07 2004-03-01 Leadd B.V. APOPTINE USE.

Also Published As

Publication number Publication date
WO2002085305A3 (en) 2003-12-18
WO2002085305A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
WO2003073826A8 (en) Novel compositions and methods for cancer
EP1578396A3 (en) Methods and compositions concerning poxviruses and cancer
EP2671581B8 (en) Compositions and methods for treating cancer
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003230750A1 (en) Compositions and methods for treating cancer
AU2002346432A1 (en) Compositions and methods for increasing cell proliferation comprising a flavonoid
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2003239129A1 (en) Methods and compositions for dna manipulation
AU2003262833A1 (en) Fluorescent glycosides and methods for their use
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002364708A1 (en) Novel compositions and methods for cancer
EP1509539A4 (en) Novel compositions and methods for cancer
EP1469769A4 (en) Novel compositions and methods for cancer
AU2002341749A1 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002258740A1 (en) Methods and compounds for decreasing cell toxicity or death
AU2002244055A1 (en) Fra-1 expression in brain cancer
AU2002337943A1 (en) Novel compositions and methods for cancer
EP1469870A4 (en) Novel compositions and methods for cancer
AU2002259005A1 (en) Compositions and methods for inducing cancer cell death
AU2002366809A1 (en) Syn3 compositions and methods
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase